Bioequivalence of n-3 fatty acids from microencapsulated fish oil formulations in human subjects

British Journal of Nutrition

Volumn 113, Issue 5, 2015, Pages 822-831

  Sanguansri, Luz ^a   Augustin, Mary Ann ^a   Lockett, Trevor J ^a   Abeywardena, Mahinda Y ^a   Royle, Peter J ^a   Mano, Mark T ^a   Patten, Glen S ^a  

^a CSIRO   (Australia)

Author keywords

Bioequivalence; Fish oil; Microencapsulation; n 3 Fatty acids

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; MILK PROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; BIOEQUIVALENCE; BLOOD SAMPLING; BODY MASS; CENTRIFUGATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG CAPSULE; DRUG FORMULATION; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FEMALE; FLAVOURED MILK; FOOD COMPOSITION; FOOD INTAKE; GEL; HUMAN; LIPID COMPOSITION; MALE; MAXIMUM PLASMA CONCENTRATION; MICROENCAPSULATION; MILK; POWDER; RANDOMIZED CONTROLLED TRIAL; SHELF LIFE; SUPERNATANT; TASTE AVERSION; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; BLOOD; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; FOOD HANDLING; INTESTINE ABSORPTION; KINETICS; METABOLISM; MIDDLE AGED; NUTRITIONAL VALUE; TIME;

ANIMALS; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; FOOD HANDLING; FOOD, FORTIFIED; HUMANS; INTESTINAL ABSORPTION; KINETICS; MALE; MIDDLE AGED; MILK; MILK PROTEINS; NUTRITIVE VALUE; TIME FACTORS;

EID: 84926419280     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451400436X     Document Type: Article

References (43)

1. Ruxton CHS, Reed SC, Simpson MJA, et al. (2007) The health benefits of omega-3 polyunsaturated fatty acids: a review of evidence. J Hum Nutr Diet 20, 275-285.
2. Wang C, Harris WS, Chung M, et al. (2006) n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84, 5-17.
3. Metcalf RG, Sanders P, James MJ, et al. (2008) Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol 101, 758-761.
4. Roth EM & Harris WS (2010) Fish oil for primary and secondary prevention of coronary heart disease. Curr Atheroscler Rep 12, 66-72.
5. Abeywardena MY & Patten GS (2011) Role of ω-3 long chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors. Endocr Metab Immune Disord Drug Targets 11, 232-246.
6. Wilk JB, Tsai MY, Hanson NQ, et al. (2012) Plasma and dietary omega-3 fatty acids, fish intake, and heart failure in the physicians' health study. Am J Clin Nutr 96, 882-888.
7. Cockbain AJ, Toogood GJ & Hull MA (2012) Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 61, 135-149.
8. Calder PC (2012) Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 3, 645-662.
9. Lee YH, Bae SC & Song GG (2012) Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. Arch Med Res 43, 356-362.
10. Miles EA & Calder PC (2012) Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr 107, S171-S184.
11. Camuesco D, Comalada M, Concha A, et al. (2006) Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA n-3 polyunsaturated fatty acids, in rats with DSS-induced colitis. Clin Nutr 25, 466-476.
12. Wiese DM, Lashner BA, Lerner E, et al. (2011) The effect of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients. Nutr Clin Pract 26, 463-473.
13. Cabre E, Manosa M & Gassull MA (2012) Omega-3 fatty acids and inflammatory bowel disease. Br J Nutr 107, S240-S252.
14. Dyall SC & Michael-Titus AT (2008) Neurological benefits of omega-3 fatty acids. Neuromol Med 10, 219-235.
15. Huang LT (2010) Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: a critical review and evaluation of the literature. J Alzheimer's Dis 21, 673-690.
16. Hooijmans CR, Pasker-de Jong PC & de Vries RBM (2012) The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis. J Alzheimer's Dis 28, 191-209.
17. Martins JG (2009) EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from meta-analysis or randomised controlled trials. J Am Coll Nutr 28, 525-542.
18. Grieger JA, Miller M & Cobiac L (2012) Knowledge and barriers to fish consumption in older Australians. Appetite 59, 456-463.
19. Mori TA (2012) Conference on 'Dietary strategies for the management of cardiovascular risk'. Dietary n-3 PUFA and CVD: a review of the evidence. Proc Nutr Soc 73, 57-64.
20. Sharma R, Sanguansri P, Marsh R, et al. (2003) Applications of microencapsulated omega-3 fatty acids in dairy products. Aust J Dairy Technol 58, 211 (extended abstract).
21. Fetterman JW Jr & Zdanowicz MM (2009) Therapeutic potential of n-3 polyunsaturated fatty acids in disease. Am J Health Syst Pharm 66, 1169-1179.
22. Tamjidi F, Nasirpour A & Shahedi M (2012) Physiochemical and sensory properties of yogurt enriched with microencapsulated fish oil. Food Sci Technol Int 18, 381-390.
23. Volker DH, Weng X & Quaggiotto P (2005) Bioavailability of long-chain polyunsaturated fatty acid enriched luncheon meats. Nutr Diet 62, 130-137.
24. Yep YL, Li D, Mann NJ, et al. (2002) Bread enriched with microencapsulated tuna oil increased plasma omega-3 fatty acids in humans. Asia Pac J Clin Nutr 11, 285-291.
25. Barrow CJ, Nolan C & Holub BJ (2009) Bioequivalence of encapsulated and micro-encapsulated fish oil supplementation. J Funct Foods 1, 38-43.
26. Arterburn LM, Hall EB & Oken H (2006) Distribution, interconversion and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83, Suppl., 1467S-1476S.
27. Patten GS, Augustin MA, Sanguansri L, et al. (2009) Site specific delivery of microencapsulated fish oil to the gastrointestinal tract of the rat. Dig Dis Sci 54, 511-521.
28. Raatz SK, Redmon JB, Wimmergren N, et al. (2009) Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil. J Am Diet Assoc 109, 1076-1081.
29. Augustin MA, Patten GS, De Luca A, et al. (2011) Intestinal passage of microencapsulated fish oil in rats following oral administration. Food Funct 2, 684-696.
30. Augustin MA, Abeywardena MY, Patten GS, et al. (2011) Effects of microencapsulation on the intestinal transit and tissue distribution of a bioactive mixture of fish oil, tributyrin and resveratrol. J Funct Foods 3, 25-37.
31. Sanguansri L, Shen Z, Weerakkody R, et al. (2013) Omega-3 fatty acids in ileal effluent after consuming different foods containing microencapsulated fish oil powder - an ileostomy study. Food Funct 4, 74-82.
32. Augustin MA, Sanguansri L & Bode O (2006) Maillard reaction products as encapsulants for fish oil powders. J Food Sci 71, E25-E32.
33. Ridges L, Sunderland R, Moerman K, et al. (2001) Cholesterol lowering benefits of soy and linseed enriched foods. Asia Pac J Clin Nutr 10, 204-211.
34. Harris WS & Von Schacky C (2004) The omega-3 index: a new risk factor for coronary heart disease? Prev Med 39, 212-220.
35. Freidewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
36. Stonehouse W, Pauga MR, Kruger R, et al. (2011) Consumption of salmon v. salmon oil capsules: effects on n-3 PUFA and selenium status. Br J Clin Nutr 106, 1231-1239.
37. Sanguansri L & Augustin MA (2001) Encapsulation of food ingredient. WO 01/74175 A1.
38. Augustin MA & Sanguansri P (2009) Nanostructured materials and the food industry. Adv Food Nutr Sci 58, 183-213.
39. Harris WS (2008) The omega-3 index as a risk factor for coronary heart disease. Am J Clin Nutr 87, 1997S-2002S.
40. Root M, Collier SR, Zwetsloot KA, et al. (2013) A randomised trial of fish oil omega-3 fatty acids on arterial health, inflammation, and metabolic syndrome in a healthy population. Nutr J 12, 40.
41. Cao J, Schwichtenberg KA, Hanson NQ, et al. (2006) Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 52, 2265-2272.
42. Pirillo A & Catapano AL (2013) Omega-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia. Atheroscler Suppl 14, 237-242.
43. Eslick GD, Howe PRC, Smith C, et al. (2009) Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol 136, 4-16.